Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation

医学 心房颤动 危险系数 四分位间距 导管消融 心力衰竭 心脏移植 外科 临床终点 心脏病学 内科学 随机对照试验 置信区间
作者
Christian Sohns,Henrik Fox,Nassir Marrouche,Harry J.G.M. Crijns,A. Costard-Jaeckle,Leonard Bergau,Gerhard Hindricks,Nikolaos Dagres,Samuel Sossalla,René Schramm,Thomas Fink,Mustapha El Hamriti,Maximilian Moersdorf,Vanessa Sciacca,Frank Konietschke,Volker Rudolph,Jan Gummert,Jan G.P. Tijssen,Philipp Sommer
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:389 (15): 1380-1389 被引量:157
标识
DOI:10.1056/nejmoa2306037
摘要

The role of catheter ablation in patients with symptomatic atrial fibrillation and end-stage heart failure is unknown. Download a PDF of the Research Summary. We conducted a single-center, open-label trial in Germany that involved patients with symptomatic atrial fibrillation and end-stage heart failure who were referred for heart transplantation evaluation. Patients were assigned to receive catheter ablation and guideline-directed medical therapy or medical therapy alone. The primary end point was a composite of death from any cause, implantation of a left ventricular assist device, or urgent heart transplantation. A total of 97 patients were assigned to the ablation group and 97 to the medical-therapy group. The trial was stopped for efficacy by the data and safety monitoring board 1 year after randomization was completed. Catheter ablation was performed in 81 of 97 patients (84%) in the ablation group and in 16 of 97 patients (16%) in the medical-therapy group. After a median follow-up of 18.0 months (interquartile range, 14.6 to 22.6), a primary end-point event had occurred in 8 patients (8%) in the ablation group and in 29 patients (30%) in the medical-therapy group (hazard ratio, 0.24; 95% confidence interval [CI], 0.11 to 0.52; P<0.001). Death from any cause occurred in 6 patients (6%) in the ablation group and in 19 patients (20%) in the medical-therapy group (hazard ratio, 0.29; 95% CI, 0.12 to 0.72). Procedure-related complications occurred in 3 patients in the ablation group and in 1 patient in the medical-therapy group. Among patients with atrial fibrillation and end-stage heart failure, the combination of catheter ablation and guideline-directed medical therapy was associated with a lower likelihood of a composite of death from any cause, implantation of a left ventricular assist device, or urgent heart transplantation than medical therapy alone. (Funded by Else Kröner-Fresenius-Stiftung; CASTLE-HTx ClinicalTrials.gov number, NCT04649801.) QUICK TAKE VIDEO SUMMARYCatheter Ablation for Advanced Heart Failure and AFib 01:59
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
博雅雅雅雅雅完成签到,获得积分10
2秒前
华仔应助陈亮采纳,获得10
2秒前
勤奋的夜春完成签到,获得积分20
3秒前
everglow发布了新的文献求助30
5秒前
琥珀川完成签到,获得积分10
5秒前
愉快之槐完成签到,获得积分10
6秒前
Owen应助悦耳听芹采纳,获得10
6秒前
沙世平完成签到,获得积分10
7秒前
科研小蔡发布了新的文献求助30
7秒前
7秒前
8秒前
甜椒完成签到,获得积分10
8秒前
8秒前
10秒前
劲秉应助英俊的小恐龙采纳,获得10
10秒前
liherong完成签到,获得积分10
10秒前
11秒前
方园完成签到,获得积分10
11秒前
11秒前
everglow完成签到,获得积分10
11秒前
WHITE完成签到,获得积分10
13秒前
陈亮发布了新的文献求助10
14秒前
南瓜头完成签到 ,获得积分10
15秒前
oui发布了新的文献求助10
16秒前
16秒前
Oliver发布了新的文献求助10
17秒前
斯文败类应助沉默的幻枫采纳,获得10
18秒前
橘子屿布丁完成签到,获得积分10
19秒前
一碘碘Q完成签到,获得积分10
19秒前
20秒前
悦耳听芹发布了新的文献求助10
20秒前
20秒前
u深度完成签到 ,获得积分10
22秒前
yanjiuhuzu完成签到,获得积分10
24秒前
lin应助lzylzy采纳,获得10
26秒前
务实青筠完成签到 ,获得积分10
26秒前
清澈水眸完成签到 ,获得积分10
26秒前
邱威完成签到 ,获得积分10
26秒前
Fjj完成签到,获得积分10
26秒前
高分求助中
All the Birds of the World 4000
Production Logging: Theoretical and Interpretive Elements 3000
Animal Physiology 2000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Am Rande der Geschichte : mein Leben in China / Ruth Weiss 1500
CENTRAL BOOKS: A BRIEF HISTORY 1939 TO 1999 by Dave Cope 1000
Machine Learning Methods in Geoscience 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3736852
求助须知:如何正确求助?哪些是违规求助? 3280817
关于积分的说明 10020999
捐赠科研通 2997447
什么是DOI,文献DOI怎么找? 1644596
邀请新用户注册赠送积分活动 782083
科研通“疑难数据库(出版商)”最低求助积分说明 749698